БИФИКОЛ®

General characteristics. Structure:

Active ingredient – the bacteria (bifidobacteria of a strain of V. of bifidum 1 and colibacillus of a strain E. сoli M17) which are lyophilicly dried up; one dose of drug contains not less than 5·107 bifidobacteria and not less than 5·107 colibacilli; one capsule contains 5 doses of drug;
 
excipients – sugar milk or lactose, magnesium stearate.
 
Main properties: drug represents the microbic mass of live bifidobacteria and colibacillus, strains according to V. of bifidum 1 and E.сoli M17 which are lyophilicly dried up. On the mechanism of action is the multifactorial medicine having antagonistic activity in relation to a number of pathogenic and opportunistic microorganisms, exerting corrective impact on бактериоценоз, stimulating reparative processes in intestines.

Pharmacological properties:

Drug has antagonistic activity in relation to a number of pathogenic and opportunistic microorganisms. Korrigirut бактериоценоз, stimulates local reparative processes in intestines; maintains balance of normal microflora, reduces a meteorism, normalizes processes of digestion and absorption in intestines, promotes improvement of local immunity and resistance of an organism of an infection.

Indications to use:

Apply to treatment of the adults and children having chronic colitis of a different etiology, treatment of convalescents after acute intestinal infections (in the presence of intestines dysfunction, allocation of pathogenic bacteriums or the expressed dysbacteriosis).

Route of administration and doses:

Drug is accepted inside in 30 minutes prior to food: adults – on 1 capsule 2 – 3 times a day; children (from 4 - 5 to 10 years) – on 1 capsule a day; children (10 years are also more senior) – on 1 capsule 2 times a day.
 
Duration of treatment is defined by weight of clinical manifestations and age of the patient and can make from 2 – 4 weeks to 3 months. At a recurrence repeated courses of treatment are reasonable. In these cases before purpose of drug the repeated research of microflora is necessary.

Features of use:

It is better to appoint drug after an antibioticotherapia course. At a heavy current of a basic disease when it is impossible to interrupt an antibioticotherapia course, drug is appointed along with antibiotics or other means of the directed action. 

Side effects:

Use of Bifikola®, as a rule, does not cause side reactions. Emergence of easy dispepsichesky frustration which take place independently is sometimes possible, without demanding drug withdrawal and assistance. More expressed reaction when it is reasonable to suspend administration of drug is in rare instances possible. If after treatment resuming by drug the expressed reaction repeats, administration of drug should be stopped.

Interaction with other medicines:

The therapeutic effect of administration of drug somewhat decreases at simultaneous use of antibiotics.

Contraindications:

Contraindications to use of Bifikola® are absent.

Storage conditions:

In the dry, protected from light place at a temperature from 2 °C to 8 °C.

Issue conditions:

Without recipe

Packaging:

On 5 doses of drug in the capsule, on 30 capsules in a plastic container.